 |
인쇄하기
취소
|
Adverse events to be put in Cymbalta and Teveten
The Ministry of Food and Drug Safety (MFDS) said on Thursday that it instructed pharmaceutical companies to add the adverse events to the instructions of two medicinal products. Among the relevant products are Lilly’s Cymbalta (dulocetine) and Handok Pharm’s Teveten (eprosartan).
The move came after MFDS reviewed the two products’ post-marketing surveillance reports.
1) A total of 103 adv...
The move came after MFDS reviewed the two products’ post-marketing surveillance reports.
1) A total of 103 adv...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.